Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Intestinal Obstruction I: Introduction01:29

Intestinal Obstruction I: Introduction

Intestinal obstruction is a partial or complete blockage of the small or large intestine that disrupts the normal flow of intestinal contents through the lumen. This interruption impairs digestion, absorption, and fluid balance, and may lead to serious complications if not treated promptly.Mechanical ObstructionMechanical obstruction occurs when a physical blockage prevents intestinal contents from passing, arising from within the lumen or the bowel wall, or from external compression.Adhesions,...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postnatal Cytomegalovirus Risk Does Not Outweigh the Benefits of Mother's Raw Milk.

NeoReviews·2026
Same author

Enteral iron dose effect on iron storage, intestinal barrier, and gut microbiome in preterm infants: a randomized clinical trial.

The American journal of clinical nutrition·2026
Same author

The future neonatologist.

Seminars in fetal & neonatal medicine·2026
Same author

Photothermal Recycling Biosensing for Continuous, Sensitive Molecular Quantification.

bioRxiv : the preprint server for biology·2026
Same author

The Future Was Yesterday: Artificial Intelligence in Newborn Medicine.

Neonatology·2026
Same author

Live biotherapeutic product IBP-9414 (L. reuteri) in very low birth weight infants: the Connection Study.

Pediatric research·2026

Related Experiment Video

Updated: Jun 30, 2026

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome
06:51

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome

Published on: July 28, 2023

A roadmap for understanding and preventing necrotizing enterocolitis.

Josef Neu1, Maka Mshvildadze, Volker Mai

  • 11600 Southwest Archer Road, Gainesville, FL 32610, USA. neuj@peds.ufl.edu

Current Gastroenterology Reports
|September 19, 2008
PubMed
Summary
This summary is machine-generated.

Necrotizing enterocolitis (NEC), a severe newborn gastrointestinal emergency, lacks a determined cause. New microbiome and metabolomic techniques may help diagnose and prevent this condition in at-risk infants.

More Related Videos

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling
09:13

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling

Published on: September 19, 2025

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

Related Experiment Videos

Last Updated: Jun 30, 2026

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome
06:51

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome

Published on: July 28, 2023

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling
09:13

A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling

Published on: September 19, 2025

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

Area of Science:

  • Neonatal medicine
  • Gastroenterology
  • Microbiology

Background:

  • Necrotizing enterocolitis (NEC) is a critical gastrointestinal emergency in newborns.
  • The exact cause of NEC remains unknown, hindering effective prevention and treatment.
  • Current understanding relies on epidemiology, clinical observations, and animal models, which have limitations in representing human infant NEC.

Purpose of the Study:

  • To explore novel approaches for understanding the etiology of NEC.
  • To highlight the potential of advanced analytical techniques in NEC research.
  • To identify new avenues for early diagnosis and prevention of NEC.

Main Methods:

  • Review of existing knowledge on NEC pathogenesis.
  • Discussion of emerging analytic techniques, including microbiome analysis (e.g., Human Microbiome Roadmap Project).
  • Exploration of proteomic and metabolomic approaches.

Main Results:

  • An immature, bacteria-colonized intestine is essential for NEC development.
  • Advanced techniques can detect previously unculturable microbes and assess microbial diversity and function.
  • Proteomics and metabolomics show promise for NEC diagnostics and prevention.

Conclusions:

  • Understanding the gut microbiome's role is crucial for NEC research.
  • New technologies offer significant potential for advancing NEC diagnosis and prevention strategies.
  • Further research integrating microbiome, proteomic, and metabolomic data is warranted for at-risk infants.